[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338498-105":59,"doc-detail-338498-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","urinary-dna-methylation-and-protein-biomarkers-identify-urothelial-carcinoma-among-other-genitourinary-diseases-and-cancer-free-individuals","Urinary DNA-methylation and protein biomarkers identify urothelial carcinoma among other genitourinary diseases and cancer-free individuals","","Background: After more than 80 years, cystoscopy remains the gold standard for identifying urothelial carcinoma (UCa), yet it is limited by patient pain and procedure costs. This study verifies urinary biomarkers CXCL16 and TGFBI at the protein level, and DNA methylation CpG sites ALOX5, TRPS1, and an intergenic region on chromosome 16 in an independent cross-sectional cohort. Methods: Urine from 1119 individuals was analyzed by methylation assays and ELISA, using statistical group comparisons and ROC performance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/urinary-dna-methylation-and-protein-biomarkers-identify-urothelial-carcinoma-among-other-genitourinary-diseases-and-cancer-free-individuals/338498/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/urinary-dna-methylation-and-protein-biomarkers-identify-urothelial-carcinoma-among-other-genitourinary-diseases-and-cancer-free-individuals/338498.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is non-invasive detection of urothelial carcinoma challenging compared with cystoscopy?","Question",{"text":112,"@type":113},"Cystoscopy is painful for patients and involves substantial costs, making non-invasive approaches difficult. The document highlights these practical limitations as key drivers for developing alternatives.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which biomarkers and DNA methylation sites were verified in this study?",{"text":117,"@type":113},"The study verified urinary protein biomarkers CXCL16 and TGFBI, and assessed DNA methylation at CpG sites ALOX5, TRPS1, and an intergenic region on chromosome 16.",{"name":119,"@type":110,"acceptedAnswer":120},"How did combining biomarkers affect diagnostic performance for UCa?",{"text":121,"@type":113},"Combining methylation markers improved detection, and integrating up to five methylation and protein markers achieved high specificity (97%) with a reported sensitivity of 72% for identifying UCa patients among cancer-free and other cancer groups.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338498,1790197666,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","Lang etal. Journal of Translational Medicine (2024) 22:1061  \n[https://doi.org/10.1186/s12967-024-05844-x](https://doi.org/10.1186/s12967-024-05844-x)  \nJournal of Translational Medicine  \n RESEARCH Open Access  \nUrinary DNA-methylation and protein biomarkers identify urothelial carcinoma among other genitourinary diseases and cancer-free individuals  \nKerstin Lang1, Christina U. Köhler 1, Katharina Wichert1, Thomas Deix2, Georg Bartsch2, Gudrun Sommer3, Christiane Lübke3, Florian Roghmann4, Moritz J. Reike4, Harald Krentel5, Katja Engellandt5, Sven Schiermeier6, Valentin Menke7, Joachim Noldus4, Thomas Behrens1, Thomas Brüning1 and Heiko U. Käfferlein 1*  \nAbstract  \nBackground For more than 80 years, cystoscopy has been the gold standard for identification of urothelial carcinoma (UCa) . Because of many factors, such as pain of the patients during this procedure or the costs involved, noninvasive detection of UCa remains a challenge. Herein, we verify our previously identified urinary biomarkers C-X-C Motif Chemokine Ligand 16 (CXCL16) and transforming growth-factor beta induced protein (TGFBI) on the protein level as well as the CpG sites ALOX5, TRPS1 and an intergenic region on Chromosome 16 on DNA methylation level in an independent cross-sectional study.  \nMethods We collected N = 1119 urines from individuals coming to urological and gynecological check-ups, followup care or patients suspicious for UCa or already diagnosed for different urologic or gynecologic cancer entities. We performed methylation analysis of various CpG sites with DNA isolated from urine sediment and quantified the concentration of the protein markers CXCL16 and TGFBI in the corresponding urine supernatant using ELISA. We tested for patient-group differences with two-sided Wilcoxon rank sum tests and examined the performance with receiver operating characteristic curves. For verification, we analyzed the marker performance with previously set cutoffvalues and marker combinations with established and experimental algorithms (with logical OR-conjunction, iterative threshold-based biomarker and score combining algorithm“PanelomiX”) .  \nResults Evaluation confirmed that our previously identified protein and DNA methylation biomarkers can distinguish UCa from frequent urological and gynecological cancers. CXCL16 and TGFBI discriminated UCa cases with a sensitivity of 31% and 56% and a specificity of 94% and 85%, respectively. Combining methylation markers resulted in UCa detection in men with a sensitivity of 54% and a specificity of 94% . Extending analysis by combining all methylation and protein markers (up to five markers in total) yielded a convincingly high specificity of 97% at a sensitivity of 72% for the identification of UCa patients within a heterogeneous collective of cancer-free individuals and patients suffering from urological or gynecological cancers.  \n*Correspondence:  \nHeiko U. Käfferlein  \n[heiko.kaefferlein@dguv.de](heiko.kaefferlein@dguv.de)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creat","cbCaisqMUGTNHaOO","https://ap.wps.com/l/cbCaisqMUGTNHaOO","pdf",1469201,16,"English","# Abstract\n## Background\n## Methods\n## Results\n# Conclusion\n# Keywords\n# Background","[{\"question\":\"Why is non-invasive detection of urothelial carcinoma challenging compared with cystoscopy?\",\"answer\":\"Cystoscopy is painful for patients and involves substantial costs, making non-invasive approaches difficult. The document highlights these practical limitations as key drivers for developing alternatives.\"},{\"question\":\"Which biomarkers and DNA methylation sites were verified in this study?\",\"answer\":\"The study verified urinary protein biomarkers CXCL16 and TGFBI, and assessed DNA methylation at CpG sites ALOX5, TRPS1, and an intergenic region on chromosome 16.\"},{\"question\":\"How did combining biomarkers affect diagnostic performance for UCa?\",\"answer\":\"Combining methylation markers improved detection, and integrating up to five methylation and protein markers achieved high specificity (97%) with a reported sensitivity of 72% for identifying UCa patients among cancer-free and other cancer groups.\"}]","Urinary DNA-methylation and protein biomarkers identify urothelial carcinoma among other genitourinary diseases and cancer-free individuals | PDF",1790023879,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e180e33e0525b44260d940f345ba034b.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6cec00f07dbe8ae8f4ca99c721c32610.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/279cc7b1e8ba5c91153900d3a73394d8.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb7395549b7a3fc62ed0e71547014fa7.webp",980,1301]